======= STMN1 ======= == Gene Information == * **Official Symbol**: STMN1 * **Official Name**: stathmin 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3925|3925]] * **UniProt**: [[https://www.uniprot.org/uniprot/P16949|P16949]] * **Interactions**: [[https://thebiogrid.org/search.php?search=STMN1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20STMN1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/151442|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Involved in the regulation of the microtubule (MT) filament system by destabilizing microtubules. Prevents assembly and promotes disassembly of microtubules. Phosphorylation at Ser- 16 may be required for axon formation during neurogenesis. Involved in the control of the learned and innate fear (By similarity). {ECO:0000250}. |Stathmin| |negative regulation of thrombin-activated receptor signaling pathway| |regulation of thrombin-activated receptor signaling pathway| |negative regulation of guanyl-nucleotide exchange factor activity| |regulation of guanyl-nucleotide exchange factor activity| |hepatocyte growth factor receptor signaling pathway| |regulation of GTP binding| |negative regulation of microtubule polymerization| |microtubule depolymerization| |negative regulation of stress fiber assembly| |negative regulation of Rho protein signal transduction| |establishment of skin barrier| |negative regulation of actin filament bundle assembly| |regulation of water loss via skin| |protein depolymerization| |negative regulation of microtubule polymerization or depolymerization| |negative regulation of G protein-coupled receptor signaling pathway| |microtubule polymerization or depolymerization| |regulation of microtubule polymerization| |negative regulation of Ras protein signal transduction| |tubulin binding| |negative regulation of small GTPase mediated signal transduction| |negative regulation of protein polymerization| |multicellular organismal water homeostasis| |mitotic cytokinesis| |water homeostasis| |mitotic spindle organization| |regulation of stress fiber assembly| |regulation of microtubule polymerization or depolymerization| |intracellular| |regulation of actomyosin structure organization| |regulation of actin filament bundle assembly| |cytoskeleton-dependent cytokinesis| |cytokinesis| |negative regulation of protein binding| |microtubule cytoskeleton organization involved in mitosis| |negative regulation of protein complex assembly| |negative regulation of supramolecular fiber organization| |cellular protein complex disassembly| |negative regulation of cytoskeleton organization| |regulation of Rho protein signal transduction| |regulation of G protein-coupled receptor signaling pathway| |spindle organization| |negative regulation of binding| |positive regulation of binding| |regulation of microtubule cytoskeleton organization| |regulation of protein binding| |regulation of microtubule-based process| |regulation of protein polymerization| |protein-containing complex disassembly| |regulation of Ras protein signal transduction| |regulation of actin filament organization| |response to virus| |microtubule| |neuron projection| |multicellular organismal homeostasis| |regulation of actin cytoskeleton organization| |regulation of small GTPase mediated signal transduction| |regulation of supramolecular fiber organization| |axonogenesis| |negative regulation of organelle organization| |regulation of binding| |skin development| |regulation of actin filament-based process| |cellular component disassembly| |axon development| |cell morphogenesis involved in neuron differentiation| |regulation of protein complex assembly| |supramolecular fiber organization| |microtubule cytoskeleton organization| |neuron projection morphogenesis| |plasma membrane bounded cell projection morphogenesis| |cell projection morphogenesis| |cell division| |regulation of body fluid levels| |negative regulation of intracellular signal transduction| |transmembrane receptor protein tyrosine kinase signaling pathway| |cell part morphogenesis| |positive regulation of cellular component movement| |regulation of cytoskeleton organization| |cell morphogenesis involved in differentiation| |mitotic cell cycle process| |neuron projection development| |microtubule-based process| |mitotic cell cycle| |negative regulation of cellular component organization| |enzyme linked receptor protein signaling pathway| |cell morphogenesis| |brain development| |head development| |neuron development| |cellular component morphogenesis| |regulation of cellular component biogenesis| |central nervous system development| |regulation of cellular component movement| |cell cycle process| |neuron differentiation| |cytoskeleton organization| |chemical homeostasis| |plasma membrane bounded cell projection organization| |negative regulation of molecular function| |cell projection organization| |negative regulation of signal transduction| |regulation of organelle organization| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |cell cycle| |negative regulation of cell communication| |negative regulation of signaling| |generation of neurons| |negative regulation of response to stimulus| |neurogenesis| |homeostatic process| |cell development| |intracellular signal transduction| |positive regulation of molecular function| |regulation of intracellular signal transduction| |protein-containing complex subunit organization| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-4.93| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|-4.4| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-4.39| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|-4.27| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|-4.07| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-3.47| |[[:results:exp485|GSK626616 14μM R08 exp485]]|-3.38| |[[:results:exp269|Bisphenol A 100μM R06 exp269]]|-3.35| |[[:results:exp210|LB-100 2μM R05 exp210]]|-2.51| |[[:results:exp243|S-trityl-L-cysteine 0.5μM R05 exp243]]|-2.39| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|-2.37| |[[:results:exp72|LB-100 4.1μM R02 exp72]]|-2.2| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|-2.16| |[[:results:exp125|GSK461364A 0.005μM R03 exp125]]|-2.16| |[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|-2.07| |[[:results:exp431|Rotenone 0.07μM R08 exp431]]|-2.02| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|-2| |[[:results:exp160|Ribavirin 10 to 15μM on day4 R04 exp160]]|-1.95| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-1.87| |[[:results:exp114|A-196 10μM R03 exp114]]|-1.86| |[[:results:exp320|ABT-702 5μM plus CoCl2 18μM R07 exp320]]|-1.79| |[[:results:exp344|Chlorpromazine 10μM R07 exp344]]|-1.77| |[[:results:exp453|B02 10μM R08 exp453]]|-1.76| |[[:results:exp534|Trientine 500μM R08 exp534]]|-1.76| |[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|-1.73| |[[:results:exp415|Trichostatin-A 0.06μM R07 exp415]]|-1.73| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|2.71| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|2.73| ^Gene^Correlation^ |[[:human genes:s:ska1|SKA1]]|0.485| |[[:human genes:t:tubb|TUBB]]|0.477| |[[:human genes:p:pfdn5|PFDN5]]|0.408| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12265 * **Expression level (log2 read counts)**: 9.32 {{:chemogenomics:nalm6 dist.png?nolink |}}